Dexmedetomidine premix formulation
US9320712B2 · kind B2 · utility
19Cited by
28References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 10, 2014 |
| Grant date | Apr 26, 2016 |
| Priority date | — |
| Expiry date | Feb 10, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.